1. Medtech Insight
  2. >>Business
  3. >>Deals

US, UK Governments Approve Stryker-Wright Deal Pending Divestments

 
• By Reed Miller

The agreements with the US Federal Trade Commission and the UK Competition and Markets Authority are the last regulatory hurdles in the way of Stryker’s planned $4bn acquisition of Wright Medical.

WASHINGTON, DC - SEPTEMBER 28, 2013: Federal Trade Commission Building in Washington, DC.

Stryker Corporation will divest its STAR total ankle replacement products and finger joint replacement products as part of an agreement with the US Federal Trade Commission (FTC) that clears the way for Stryker to complete its planned acquisition of Wright Medical Group N.V., the companies announced on 4 November.

Following the regulatory approvals, Stryker was able to close the acquisition of Wright on 11 November. (Also see "Stryker Sees ‘V-Shape’ Recovery In Third Quarter" - Medtech Insight, 30...

More from Deals

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.

Deals Shaping The Medtech And Diagnostics Industries, March 2025

 
• By Medtech Insight Team

An interactive look at medtech and diagnostics deals made during March 2025. Data courtesy of Biomedtracker.

Roar Of Eargo-hearX Merger Echoes Through US OTC Hearing Aid Market

 
• By Malcolm Spicer

The firms recently announced they will operate as combined company LXE Hearing marketing Eargo’s namesake line and hearX’s Lexie brands. Eargo majority owner Patient Square Capital added $100m to its investment.

Anglonordic 25: Women’s Health Needs Therapeutic Success To Encourage Wider Investment

 
• By Natasha Barrow

Health tech is at the forefront of the women's health sector, securing 38% of venture capital in 2024. However, panelists at the Anglonordic Life Science Conference held 3 April asserted that a successful therapeutic breakthrough is key to gaining investor confidence and accelerating venture capital.

More from Business